Le Lézard
Classified in: Health
Subjects: PDT, SCZ

InventHelp Inventor Develops Medical Alarm Device (HLW-2170)


PITTSBURGH, Feb. 20, 2020 /PRNewswire/ -- An inventor from Fort Pierce, Fla., has developed the LIFE WATCH, a new type of medical alarm device. Instead of being designed to contact a central monitoring service upon manual activation, it is designed to continuously monitor an individual's vital signs and places an alert call to local emergency services.

InventHelp Logo (PRNewsfoto/InventHelp)

"My job as a firefighter inspired me to develop my idea. I wanted to help save lives during medical emergencies," said the inventor. The LIFE WATCH offers a new type of medical alarm design. It provides protection for individuals at risk for medical emergencies. This device provides an almost instant alert of a medical problem. It automatically contacts local emergency services, which allows medical intervention to occur quickly. In turn, this device may save lives. Ultimately, it may provide peace of mind to family members, as it acts as a watchful eye and useful tool when loved ones are alone. This medical device is adaptable for use on most individuals.

The original design was submitted to the Hollywood sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 18-HLW-2170, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.

SOURCE InventHelp


These press releases may also interest you

at 08:05
FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV
Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide...

at 08:05
Medicenna Therapeutics Announces CA$20 Million Investment from RA Capital Management
Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (MDNAF: OTCQB), a clinical-stage immunotherapy company focused on the development of engineered cytokines, today announced a CA$20 million investment by RA Capital Management, a multi-stage...

at 08:02
Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia A
Sobi® today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending approval of efanesoctocog alfa, for the treatment and prevention of bleeds and perioperative...

at 08:00
Citius Pharmaceuticals Announces $15 Million Registered Direct Offering
Citius Pharmaceuticals Inc. ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that it has entered into definitive...

at 08:00
Lucio Gordan, MD Serves on Panel of Oncology Leaders Sharing Insights with Oncology Fellows
Florida Cancer Specialists & Research Institute, LLC (FCS) President & Managing Physician Lucio N. Gordan, MD will serve as a panelist at the 2024 Oncology Fellows & Faculty Forum in Miami, sponsored by PrecisCa and the Community Oncology Alliance...

at 08:00
Renibus Therapeutics Announces Oral Presentations on RBT-1 at AATS and SCA Medical Conferences
Renibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardio, renal and metabolic diseases, today announced its participation at two prestigious medical conferences: the American...

More news about Health...


News published on and distributed by: